UncategorizedManifold Bio inks $2bn Roche collab to develop next-gen brain shuttles Empower Meds / November 4, 2025
UncategorizedNative Microbials and Zesty Paws form partnership to advance pet health – Longevity.Technology Empower Meds / November 4, 2025
UncategorizedLife Biosciences appoints David Guyer to board of directors – Longevity.Technology Empower Meds / November 4, 2025
UncategorizedNautilus and the Buck harness proteomics in aging research Empower Meds / November 3, 2025
UncategorizedWell subsidiary Wellstar secures $62M to advance pre-spinout growth – Longevity.Technology Empower Meds / November 3, 2025
Uncategorized4DMT signs exclusive license deal with Otsuka for 4D-150 in Asia-Pacific – Longevity.Technology Empower Meds / November 3, 2025
UncategorizedTectonic Therapeutic reports positive Phase 1b results for TX45 in pulmonary hypertension – Longevity.Technology Empower Meds / November 3, 2025
UncategorizedGenSight Biologics receives US approval for expanded access use of LUMEVOQ – Longevity.Technology Empower Meds / November 3, 2025
